{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:23:25Z","timestamp":1790857405793,"version":"4.1.0"},"reference-count":158,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1097\/01.shk.0000191343.21228.78","type":"journal-article","created":{"date-parts":[[2005,12,21]],"date-time":"2005-12-21T04:20:00Z","timestamp":1135138800000},"page":"107-119","source":"Crossref","is-referenced-by-count":91,"title":["NEUTRALIZATION OF TUMOR NECROSIS FACTOR IN PRECLINICAL MODELS OF SEPSIS"],"prefix":"10.1097","volume":"24","author":[{"given":"Jos\u00e9 A","family":"Lorente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210213","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families.","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N Engl J Med"},{"key":"R2-18-20210213","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology.","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"R3-18-20210213","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.shk.0000157301.87051.77","article-title":"Opposing effects of tumor necrosis factor receptor 1 and 2 in sepsis due to cecal ligation and puncture.","volume":"23","author":"Ebach","year":"2005","journal-title":"Shock"},{"key":"R4-18-20210213","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.4049\/jimmunol.160.7.3427","article-title":"Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis.","volume":"160","author":"Deckert-Schluter","year":"1998","journal-title":"J Immunol"},{"key":"R5-18-20210213","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1084\/jem.20040435","article-title":"Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases.","volume":"200","author":"Xanthoulea","year":"2004","journal-title":"J Exp Med"},{"key":"R6-18-20210213","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.128.5.2374","article-title":"Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice.","volume":"128","author":"Yother","year":"1982","journal-title":"J Immunol"},{"key":"R7-18-20210213","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1073\/pnas.82.24.8667","article-title":"Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.","volume":"82","author":"Gamble","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"R8-18-20210213","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1084\/jem.177.5.1277","article-title":"Tumor necrosis factor- (TNF-)-induced cell adhesion to human endothelial cells is under dominant control of one TNF- receptor type, TNF--R55.","volume":"177","author":"Mackay","year":"1993","journal-title":"J Exp Med"},{"key":"R9-18-20210213","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4049\/jimmunol.156.4.1587","article-title":"Crucial role of 55-kilodalton TNF- receptor in TNF--induced adhesion molecule expression and leukocyte organ infiltration.","volume":"156","author":"Neumann","year":"1996","journal-title":"J Immunol"},{"key":"R10-18-20210213","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/IAI.63.9.3272-3278.1995","article-title":"Role of tumor necrosis factor in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.","volume":"63","author":"Gosselin","year":"1995","journal-title":"Infect Immun"},{"key":"R11-18-20210213","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/infdis\/171.3.570","article-title":"Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxin shock yet impairs pulmonary host defense.","volume":"171","author":"Kolls","year":"1995","journal-title":"J Infect Dis"},{"key":"R12-18-20210213","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1128\/IAI.64.12.5211-5218.1996","article-title":"Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia.","volume":"64","author":"Laichalk","year":"1996","journal-title":"Infect Immun"},{"key":"R13-18-20210213","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/infdis\/162.6.1349","article-title":"Tumor necrosis factor- plays a role in host defense against Histoplasma capsulatum.","volume":"162","author":"Smith","year":"1990","journal-title":"J Infect Dis"},{"key":"R14-18-20210213","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.4049\/jimmunol.143.9.2894","article-title":"Evidence that tumor necrosis factor has an important role in antibacterial resistance.","volume":"143","author":"Havell","year":"1989","journal-title":"J Immunol"},{"key":"R15-18-20210213","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1128\/IAI.58.6.1572-1576.1990","article-title":"A role in vivo for tumor necrosis factor in host defense against Chlamydia trachomatis.","volume":"58","author":"Williams","year":"1990","journal-title":"Infect Immun"},{"key":"R16-18-20210213","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/IAI.65.4.1139-1146.1997","article-title":"Alveolar macropahges are required for protective pulmonary defenses in Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival.","volume":"65","author":"Broug-Holub","year":"1997","journal-title":"Infect Immun"},{"key":"R17-18-20210213","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.144.5.1935","article-title":"Protective effect of recombinant tumor necrosis factor- in murine salmonellosis.","volume":"144","author":"Nakano","year":"1990","journal-title":"J Immunol"},{"key":"R18-18-20210213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0882-4010(91)90091-N","article-title":"Serum TNF- in mouse typhoid and enhancement of a salmonella infection by anti-TNF- antibodies.","volume":"11","author":"Mastroeni","year":"1991","journal-title":"Microb Pathog"},{"key":"R19-18-20210213","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1128\/IAI.56.10.2563-2569.1988","article-title":"Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes.","volume":"56","author":"Nakane","year":"1988","journal-title":"Infect Immun"},{"key":"R20-18-20210213","first-page":"1935","article-title":"Role of TNF- and IL-1 in infections with Toxoplasma gondii.","volume":"144","author":"Chang","year":"1990","journal-title":"Immunology"},{"key":"R21-18-20210213","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/IAI.58.10.3168-3172.1990","article-title":"Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis.","volume":"58","author":"Holtmann","year":"1990","journal-title":"Infect Immun"},{"key":"R22-18-20210213","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.157.5.2155","article-title":"TNF receptors in murine Candida albicans infection.","volume":"157","author":"Steinshamn","year":"1996","journal-title":"J Immunol"},{"key":"R23-18-20210213","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/eji.1830220617","article-title":"Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor- and granulocyte-macrophage colony stimulating factor for phagocytosis of Cryptococcus neoformans.","volume":"22","author":"Collins","year":"1992","journal-title":"Eur J Immunol"},{"key":"R24-18-20210213","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"R25-18-20210213","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1128\/IAI.58.8.2675-2677.1990","article-title":"Activation of tuberculostatis macrophage functions by interferon, interleukin 4 and tumor necrosis factor.","volume":"58","author":"Flesh","year":"1990","journal-title":"Infect Immun"},{"key":"R26-18-20210213","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/IAI.65.2.457-465.1997","article-title":"Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzii infecion in mice.","volume":"65","author":"Lima","year":"1997","journal-title":"Infect Immun"},{"key":"R27-18-20210213","first-page":"156","article-title":"Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor.","volume":"106","author":"Sheppard","year":"1989","journal-title":"Surgery"},{"key":"R28-18-20210213","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/infdis\/159.2.189","article-title":"Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response.","volume":"59","author":"Nelson","year":"1989","journal-title":"J Infect Dis"},{"key":"R29-18-20210213","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00003246-198906000-00001","article-title":"Plasma tumor necrosis factor and mortality in critically ill septic patients.","volume":"17","author":"Debets","year":"1989","journal-title":"Crit Care Med"},{"key":"R30-18-20210213","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1084\/jem.169.1.333","article-title":"The complex pattern of cytokines in serum from patients with meningococcal septic shock.","volume":"169","author":"Waage","year":"1989","journal-title":"J Exp Med"},{"key":"R31-18-20210213","first-page":"32","article-title":"Serum cachectin\/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality.","volume":"170","author":"Marano","year":"1990","journal-title":"Surg Gynecol Obstet"},{"key":"R32-18-20210213","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.4049\/jimmunol.155.10.5038","article-title":"Effects of recombinant dimeric TNF- receptor on human inflammatory responses following intravenous endotoxin administration.","volume":"155","author":"Suffredini","year":"1995","journal-title":"J Immunol"},{"key":"R33-18-20210213","first-page":"415","article-title":"Cachectin\/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.","volume":"164","author":"Tracey","year":"1987","journal-title":"Surg Gynecol Obstet"},{"key":"R34-18-20210213","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.169.3.823","article-title":"Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.","volume":"169","author":"Natanson","year":"1989","journal-title":"J Exp Med"},{"key":"R35-18-20210213","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.3895437","article-title":"Passive immunization against cachectin\/tumor necrosis factor protects mice from lethal effect of endotoxin.","volume":"229","author":"Beutler","year":"1985","journal-title":"Science"},{"key":"R36-18-20210213","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1172\/JCI113540","article-title":"Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.","volume":"81","author":"Mathison","year":"1988","journal-title":"J Clin Invest"},{"key":"R37-18-20210213","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF- monoclonal antibodies prevent septic shock during lethal bacteraemia.","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"R38-18-20210213","first-page":"279","article-title":"Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF).","volume":"30","author":"Hinshaw","year":"1990","journal-title":"Circ Shock"},{"key":"R39-18-20210213","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/IAI.67.2.595-601.1999","article-title":"Tumor necrosis factor receptor 1 is important for survival from Streptococcus pneumoniae infections.","volume":"67","author":"OBrien","year":"1999","journal-title":"Infect Immun"},{"key":"R40-18-20210213","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1128\/IAI.69.11.6881-6886.2001","article-title":"Effect of deficiency of tumor necrosis factor or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis.","volume":"69","author":"Wellmer","year":"2001","journal-title":"Infect Immun"},{"key":"R41-18-20210213","first-page":"138","article-title":"Production of tumor necrosis factor- and interleukin-6 in mice infected with group B streptococci.","volume":"38","author":"Teti","year":"1992","journal-title":"Circ Shock"},{"key":"R42-18-20210213","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1574-695X.2000.tb01522.x","article-title":"Effect of a matrix metalloproteinase inhibitor on host resistance against Listeria monocytogenes infection.","volume":"29","author":"Yamada","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R43-18-20210213","first-page":"175","article-title":"Effect of anti-TNF- treatment in an antibiotic treated murine model of shock due to Streptococcus pyogenes.","volume":"1120","author":"Martin","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"R44-18-20210213","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00003246-199308000-00022","article-title":"Observations on the role of tumor necrosis factor- in a murine model of shock due to Streptococcus pyogenes.","volume":"21","author":"Wayte","year":"1993","journal-title":"Crit Care Med"},{"key":"R45-18-20210213","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/089419301753170075","article-title":"Anti-TNF- antibody treatment has no positive effect on survival in a model of pneumococcal sepsis in pigs.","volume":"14","author":"Gawad","year":"2001","journal-title":"J Invest Surg"},{"key":"R46-18-20210213","first-page":"96","article-title":"Effects of anti-cytokine treatments in neonatal sepsis models.","volume":"7","author":"Teti","year":"1995","journal-title":"J Chemother"},{"key":"R47-18-20210213","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/AAC.34.6.1100","article-title":"Efficacy, toxicity, and pharmacokinetics of pentoxifyline and its analogs in experimental Staphylococcus aureus infections.","volume":"34","author":"Maderazo","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"R48-18-20210213","first-page":"49","article-title":"Efficacy of TNF- inhibitors in neonatal sepsis models.","volume":"9","author":"Mancuso","year":"1994","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R49-18-20210213","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1128\/IAI.59.6.2110-2115.1991","article-title":"Tumor necrosis factor mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.","volume":"59","author":"Freudenberg","year":"1991","journal-title":"Infect Immun"},{"key":"R50-18-20210213","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1128\/IAI.70.12.6628-6637.2002","article-title":"Anomalous role of tumor necrosis factor in experimental enterococcal infection.","volume":"70","author":"Papasian","year":"2002","journal-title":"Infect Immun"},{"key":"R51-18-20210213","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00005373-199210000-00013","article-title":"Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF- antibody.","volume":"33","author":"Hinshaw","year":"1992","journal-title":"J Trauma"},{"key":"R52-18-20210213","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/173.3.619","article-title":"Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure.","volume":"173","author":"Stevens","year":"1996","journal-title":"J Infect Dis"},{"key":"R53-18-20210213","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/intimm\/10.1.37","article-title":"Defective co-stimulation and impaired Th1 development in tumor necrosis factor\/lymphotoxin double-deficient mice infected with Candida albicans.","volume":"10","author":"Mencacci","year":"1998","journal-title":"Int Immunol"},{"key":"R54-18-20210213","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2249.1996.d01-870.x","article-title":"Contribution of tumour necrosis factor- (TNF-) in host defence mechanisms against Cryptococcus neoformans.","volume":"106","author":"Kawakami","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"R55-18-20210213","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/IAI.63.5.1725-1731.1995","article-title":"Role of tumor necrosis factor and interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice.","volume":"63","author":"Aguirre","year":"1995","journal-title":"Infect Immun"},{"key":"R56-18-20210213","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.4049\/jimmunol.157.10.4529","article-title":"Afferent phase production of TNF- is required for the development of protective T cell immunity to Cryptococcus neoformans.","volume":"157","author":"Huffnagle","year":"1996","journal-title":"J Immunol"},{"key":"R57-18-20210213","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1086\/315061","article-title":"Enhanced sensitivity of tumor necrosis factor\/lymphotoxin-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite\/nitrate, interferon-, and interleukin 12.","volume":"180","author":"Rayhane","year":"1999","journal-title":"J Infect Dis"},{"key":"R61-18-20210213","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-\/mediated toxicity but highly susceptible to infection by Listeria monocytogenes.","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature"},{"key":"R62-18-20210213","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.4049\/jimmunol.139.12.4225","article-title":"Production of tumor necrosis factor during murine listeriosis.","volume":"139","author":"Havell","year":"1987","journal-title":"J Immunol"},{"key":"R63-18-20210213","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00198530","article-title":"Role of tumor necrosis factor in Listeria resistance of nude mice.","volume":"179","author":"Hauser","year":"1990","journal-title":"Med Microbiol Immunol"},{"key":"R64-18-20210213","first-page":"316","article-title":"Human rTNF- augments antibacterial resistance in mice: potentiation of its effects by recombinant human IL-1.","volume":"69","author":"Roll","year":"1990","journal-title":"Immunology"},{"key":"R65-18-20210213","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1128\/IAI.57.5.1615-1617.1989","article-title":"Protection of mice against Listeria monocytogenes infection by recombinant human tumor necrosis factor .","volume":"57","author":"Desiderio","year":"1989","journal-title":"Infect Immun"},{"key":"R66-18-20210213","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","article-title":"TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.","volume":"160","author":"Peschon","year":"1998","journal-title":"J Immunol"},{"key":"R67-18-20210213","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxin shock yet succumb to L. monocytogenes infection.","volume":"73","author":"Pfeffer","year":"1993","journal-title":"Cell"},{"key":"R68-18-20210213","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/intimm\/8.1.23","article-title":"Multiple immune abnormalities in tumor necrosis factor and lymphotoxin- double-deficient mice.","volume":"8","author":"Eugster","year":"1996","journal-title":"Int Immunol"},{"key":"R69-18-20210213","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.181.2.607","article-title":"Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.","volume":"181","author":"Sheehan","year":"1995","journal-title":"J Exp Med"},{"key":"R70-18-20210213","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/eji.1830270434","article-title":"Mice heterozygous for a deletion of the tumor necrosis factor- and lymphotoxin- genes: biological importance of a nonlinear response of tumor necrosis factor- to gene dosage.","volume":"27","author":"Amiot","year":"1997","journal-title":"Eur J Immunol"},{"key":"R71-18-20210213","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/BF03401722","article-title":"Lipopolysaccharide-induced cytokine cascade and lethality in LT\/TNF-deficient mice.","volume":"3","author":"Amiot","year":"1997","journal-title":"Mol Med"},{"key":"R72-18-20210213","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/eji.1830250841","article-title":"Transgenic mice expressing high levels of soluble TNF--R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.","volume":"25","author":"Garcia","year":"1995","journal-title":"Eur J Immunol"},{"key":"R73-18-20210213","first-page":"104","article-title":"Divergent effects of tumor necrosis factor- and lymphotoxin- on lethal endotoxemia and infection with live Salmonella typhimurium in mice.","volume":"13","author":"Dharmana","year":"2002","journal-title":"Eur Cytokine Netw"},{"key":"R74-18-20210213","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/IAI.66.7.3355-3364.1998","article-title":"Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor p55 receptors.","volume":"66","author":"Everest","year":"1998","journal-title":"Infect Immun"},{"key":"R75-18-20210213","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1006\/mpat.1993.1046","article-title":"Effect of late administration of anti-TNF antibodies on a Salmonella infection in the mouse model.","volume":"14","author":"Mastroeni","year":"1993","journal-title":"Microb Pathog"},{"key":"R76-18-20210213","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/infdis\/171.2.400","article-title":"Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus.","volume":"171","author":"Adams","year":"1995","journal-title":"J Infect Dis"},{"key":"R77-18-20210213","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural deficiencies in granuloma formation in TNF- gene-targeted mice underlie the hightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.","volume":"162","author":"Bean","year":"1999","journal-title":"J Immunol"},{"key":"R78-18-20210213","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1128\/IAI.68.12.6954-6961.2000","article-title":"Immunopathologic effects of tumor necrosis factor in murine mycobacterial infection are dose dependent.","volume":"68","author":"Bekker","year":"2000","journal-title":"Infect Immun"},{"key":"R79-18-20210213","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor- is required in the protective immune response against Mycobacterium tuberculosis in mice.","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"key":"R80-18-20210213","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jlb.50.5.495","article-title":"Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis.","volume":"50","author":"Denis","year":"1991","journal-title":"J Leukocyte Biol"},{"key":"R81-18-20210213","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.4049\/jimmunol.143.9.2996","article-title":"Treatment of Mycobacterium avium complex infection in mice with recombinant human interleukin-2 and tumor necrosis factor.","volume":"143","author":"Bermudez","year":"1989","journal-title":"J Immunol"},{"key":"R82-18-20210213","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/IAI.70.4.2082-2089.2002","article-title":"Local role of tumor necrosis factor in pulmonary inflammatory response to Mycobacterium tuberculosis infection.","volume":"70","author":"Smith","year":"2002","journal-title":"Infect Immun"},{"key":"R83-18-20210213","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/archsurg.1996.01430230098017","article-title":"Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors.","volume":"131","author":"Acton","year":"1996","journal-title":"Arch Surg"},{"key":"R84-18-20210213","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/163.1.83","article-title":"Divergent efficacy of antibody to tumor necrosis factor- in intravascular and peritonitis models of sepsis.","volume":"163","author":"Bagby","year":"1991","journal-title":"J Infect Dis"},{"key":"R85-18-20210213","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/00003246-199509000-00011","article-title":"Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor antibody in Escherichia coli sepsis in the rabbit.","volume":"23","author":"Stack","year":"1995","journal-title":"Crit Care Med"},{"key":"R86-18-20210213","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00024382-200013020-00011","article-title":"Suppression of lethal toxicity of endotoxin by biscoclaurine alkaloid cepharanthin.","volume":"13","author":"Maruyama","year":"2000","journal-title":"Shock"},{"key":"R87-18-20210213","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/jpsu.2000.6862","article-title":"The role of anti-tumor necrosis factor- and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.","volume":"35","author":"Lally","year":"2000","journal-title":"J Pediatr Surg"},{"key":"R88-18-20210213","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2958.1992.tb01505.x","article-title":"Tumor necrosis factor antibody protects against lethal meningococcaemia.","volume":"6","author":"Nassif","year":"1992","journal-title":"Mol Microbiol"},{"key":"R89-18-20210213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/107999099314397","article-title":"Targeting macrophages with microspheres containing cytokine-neutralizaing antibodies prevents lethality in gram-negative peritonitis.","volume":"19","author":"Oettinger","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"R90-18-20210213","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.4049\/jimmunol.148.9.2724","article-title":"Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.","volume":"148","author":"Eskandari","year":"1992","journal-title":"J Immunol"},{"key":"R91-18-20210213","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.145.11.3762","article-title":"Requirement of endogenous tumor necrosis factor\/cachectin for recovery from experimental peritonitis.","volume":"145","author":"Echtenacher","year":"1990","journal-title":"J Immunol"},{"key":"R92-18-20210213","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/IAI.69.6.3550-3555.2001","article-title":"Tumor necrosis factor-dependent adhesions as a major protective mechanism eraly in septic peritonitis in mice.","volume":"69","author":"Echtenacher","year":"2001","journal-title":"Infect Immun"},{"key":"R93-18-20210213","first-page":"85","article-title":"Cellular and molecular mechanisms of TNF- protection in septic peritonitis.","volume":"47","author":"Echtenacher","year":"1995","journal-title":"J Inflamm"},{"key":"R94-18-20210213","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.4049\/jimmunol.165.11.6496","article-title":"Intrapulmonary TNF- gene therapy reverses sepsis-induced suppression of lung antibacterial host defense.","volume":"165","author":"Chen","year":"2000","journal-title":"J Immunol"},{"key":"R95-18-20210213","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00005373-199703000-00008","article-title":"Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis.","volume":"42","author":"Cooney","year":"1997","journal-title":"J Trauma"},{"key":"R96-18-20210213","first-page":"279","article-title":"Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models.","volume":"29","author":"Evans","year":"1989","journal-title":"Circ Shock"},{"key":"R97-18-20210213","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.4049\/jimmunol.148.6.1890","article-title":"Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy to antibodies to tumor necrosis factor- and to lipopolysaccharide.","volume":"148","author":"Zanetti","year":"1992","journal-title":"J Immunol"},{"key":"R98-18-20210213","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/jsre.1995.1147","article-title":"PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock.","volume":"59","author":"Espat","year":"1995","journal-title":"J Surg Res"},{"key":"R99-18-20210213","first-page":"E621","article-title":"Prevention of skeletal muscle catabolism does not impair visceral protein metabolism.","volume":"270","author":"Cooney","year":"1996","journal-title":"Am J Physiol"},{"key":"R100-18-20210213","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1128\/IAI.63.9.3253-3258.1995","article-title":"In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor and nitric oxide.","volume":"63","author":"Brieland","year":"1995","journal-title":"Infect Immun"},{"key":"R101-18-20210213","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/ajrccm.155.2.9032201","article-title":"Passive immunization against tumor necrosis factor- impairs host defense during pneumococcal pneumonia in mice.","volume":"155","author":"Van der Poll","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R102-18-20210213","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.4049\/jimmunol.167.9.5240","article-title":"TNF- compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia.","volume":"167","author":"Rijneveld","year":"2001","journal-title":"J Immunol"},{"key":"R103-18-20210213","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1086\/376454","article-title":"Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia.","volume":"188","author":"Rijneveld","year":"2003","journal-title":"J Infect Dis"},{"key":"R104-18-20210213","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1128\/IAI.71.9.4891-4900.2003","article-title":"Increased mortality and dysregulated cytokine production in tumor necrosis factor receptor 1-deficient mice following systemic Klebsiella pneumoniae infection.","volume":"71","author":"Moore","year":"2003","journal-title":"Infect Immun"},{"key":"R105-18-20210213","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00000542-200307000-00016","article-title":"Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.","volume":"99","author":"Karzai","year":"2003","journal-title":"Anesthesiology"},{"key":"R106-18-20210213","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1164\/ajrccm.150.3.8087341","article-title":"Compartmentalized cytokine production within the human lung in unilateral pneumonia.","volume":"150","author":"Dehoux","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R107-18-20210213","first-page":"1335","article-title":"Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type 1 inhibits acute inflammation.","volume":"142","author":"Ulrich","year":"1993","journal-title":"Am J Pathol"},{"key":"R108-18-20210213","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00024382-199407000-00002","article-title":"Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model.","volume":"2","author":"Schlag","year":"1994","journal-title":"Shock"},{"key":"R109-18-20210213","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/infdis\/162.2.421","article-title":"Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor- in experimental gram-negative shock.","volume":"162","author":"Silva","year":"1990","journal-title":"J Infect Dis"},{"key":"R110-18-20210213","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/eji.1830211134","article-title":"Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality.","volume":"21","author":"Lesslauer","year":"1991","journal-title":"Eur J Immunol"},{"key":"R111-18-20210213","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1006\/cyto.1996.0094","article-title":"Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine.","volume":"8","author":"Sironi","year":"1996","journal-title":"Cytokine"},{"key":"R112-18-20210213","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.173.6.1305","article-title":"Protective effect of chlorpromazine on endotoxin toxicity and TNF- production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock.","volume":"173","author":"Gadina","year":"1991","journal-title":"J Exp Med"},{"key":"R113-18-20210213","doi-asserted-by":"crossref","first-page":"10535","DOI":"10.1073\/pnas.88.23.10535","article-title":"Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.","volume":"88","author":"Ashkenazi","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"R114-18-20210213","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/CDLI.6.4.594-598.1999","article-title":"Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.","volume":"6","author":"Krakauer","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"R115-18-20210213","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/rccm.200204-302OC","article-title":"Risk and the efficacy of anti-inflammatory agents: retrospective and confirmatory studies of sepsis.","volume":"166","author":"Eichacker","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R116-18-20210213","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00003246-200103000-00006","article-title":"Lenercept (p55 tumor necrosis receptor fusion protein) in severe sepsis and early septic shock. A randomized double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit Care Med"},{"key":"R117-18-20210213","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis.","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"R118-18-20210213","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00003246-199612000-00021","article-title":"Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis.","volume":"24","author":"Piper","year":"1996","journal-title":"Crit Care Med"},{"key":"R119-18-20210213","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000658-199108000-00008","article-title":"The complex pattern of cytokines in sepsis: association between prostaglandins, cachectin, and interleukins.","volume":"214","author":"Ertel","year":"1991","journal-title":"Ann Surg"},{"key":"R120-18-20210213","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/infdis\/162.2.454","article-title":"Monoclonal antibody to endotoxin core protects mice from Escherichia coli sepsis by a mechanism independent of tumor necrosis factor and interleukin-6.","volume":"162","author":"Silva","year":"1990","journal-title":"J Infect Dis"},{"key":"R121-18-20210213","first-page":"766","article-title":"In vivo dynamics of murine tumor necrosis factor- gene expression: kinetics of dexamethasone-induced suppression.","volume":"60","author":"Remick","year":"1990","journal-title":"Lab Invest"},{"key":"R122-18-20210213","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0192-0561(85)90002-5","article-title":"Production of tumor necrosis factor in Listeria monocytogenes-infected animals.","volume":"7","author":"Ha","year":"1985","journal-title":"Int J Immunopharmacol"},{"key":"R123-18-20210213","first-page":"171","article-title":"Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor.","volume":"31","author":"Schade","year":"1990","journal-title":"Circ Shock"},{"key":"R124-18-20210213","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0024-3205(90)90474-6","article-title":"Pentoxifylline inhibits lipopolysacchride-induced serum tumor necrosis factor and mortality.","volume":"47","author":"Noel","year":"1990","journal-title":"Life Sci"},{"key":"R125-18-20210213","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1067\/mlc.2003.32","article-title":"Tumor necrosis factor- inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock.","volume":"141","author":"Rodriguez-Wilhelmi","year":"2003","journal-title":"J Lab Clin Med"},{"key":"R126-18-20210213","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1128\/IAI.59.8.2609-2614.1991","article-title":"Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival.","volume":"59","author":"Franks","year":"1991","journal-title":"Infect Immun"},{"key":"R127-18-20210213","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/infdis\/171.2.393","article-title":"Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice.","volume":"171","author":"Netea","year":"1995","journal-title":"J Infect Dis"},{"key":"R128-18-20210213","first-page":"306","article-title":"Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis versus disseminated candidiasis with fungal septic shock.","volume":"39","author":"Lechner","year":"1993","journal-title":"Circ Shock"},{"key":"R129-18-20210213","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/ajrccm\/143.3.598","article-title":"Group B streptococcus induces tumor necrosis factor in neonatal piglets: effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamic and gas exchange.","volume":"143","author":"Gibson","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"R130-18-20210213","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1172\/JCI115390","article-title":"Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.","volume":"88","author":"Opal","year":"1991","journal-title":"J Clin Invest"},{"key":"R131-18-20210213","first-page":"348","article-title":"Enhanced survival from cecal ligation and puncture with pentoxifylline is associated with altered neutrophil trafficking and reduced interleukin-1 expression but not inhibition of tumor necrosis factor synthesis.","volume":"116","author":"Hadjiminas","year":"1994","journal-title":"Surgery"},{"key":"R132-18-20210213","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1084\/jem.164.4.1368","article-title":"Cachetin\/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.","volume":"164","author":"Tracey","year":"1986","journal-title":"J Exp Med"},{"key":"R133-18-20210213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(88)90486-2","article-title":"A novel form of TNF\/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF-.","volume":"53","author":"Kriegler","year":"1988","journal-title":"Cell"},{"key":"R134-18-20210213","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/ajrccm.159.4.9712012","article-title":"LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.","volume":"159","author":"Mignon","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R135-18-20210213","first-page":"75","article-title":"Efficacy of monoclonal antibody against tumor necrosis factor in an endotoxemic baboon model.","volume":"38","author":"Emerson","year":"1992","journal-title":"Circ Shock"},{"key":"R136-18-20210213","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1152\/jappl.1998.84.4.1119","article-title":"Pharmacogenetics, immunogenicity, and efficacy of dimeric TNFR-binding proteins in healthy and bacteremic baboon.","volume":"84","author":"Solorzano","year":"1998","journal-title":"J Appl Physiol"},{"key":"R137-18-20210213","first-page":"574","article-title":"Monoclonal antibody to tumor necrosis factor- prevents lethal endotoxin sepsis in adult rhesus monkeys.","volume":"120","author":"Fiedler","year":"1992","journal-title":"J Lab Clin Med"},{"key":"R138-18-20210213","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2249.1993.tb05924.x","article-title":"Role of tumour necrosis factor and reactive oxyfen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality.","volume":"91","author":"Gatti","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"R139-18-20210213","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0165-2478(88)90003-X","article-title":"Monoclonal antibodies against human recombinant tumor necrosis factor: prevention of endotoxic shock.","volume":"17","author":"Shimamoto","year":"1988","journal-title":"Immunol Lett"},{"key":"R140-18-20210213","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1084\/jem.179.3.849","article-title":"Differential effect of isotype on efficacy of anti-tumor necrosis factor chimeric antibodies in experimental septic shock.","volume":"179","author":"Suitters","year":"1994","journal-title":"J Exp Med"},{"key":"R141-18-20210213","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00000658-199604000-00012","article-title":"A role for tumor necrosis factor- in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction.","volume":"223","author":"Espat","year":"1996","journal-title":"Ann Surg"},{"key":"R142-18-20210213","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumor necrosis factor TNF- receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF- carriers and TNF- antagonists.","volume":"151","author":"Mohler","year":"1993","journal-title":"J Immunol"},{"key":"R143-18-20210213","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0883-9441(97)90023-X","article-title":"A recombinant tumor necrosis factor-a p80 receptor:Fc fusion protein decreases circulating bioactive tumor necrosis factor- but not lung injury or mortality during immunosuppression-related gram-negative bacteremia.","volume":"12","author":"Lechner","year":"1997","journal-title":"J Crit Care"},{"key":"R144-18-20210213","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein.","volume":"334","author":"Fisher","year":"1996","journal-title":"N Engl J Med"},{"key":"R145-18-20210213","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jemt.1070260512","article-title":"Acute lung injury during bacterial or fungal sepsis.","volume":"26","author":"Lechner","year":"1993","journal-title":"Microcirc Res Technol"},{"key":"R146-18-20210213","first-page":"L526","article-title":"Differential systemic and intrapulmonary TNF- production in Candida sepsis during immunosuppression.","volume":"263","author":"Lechner","year":"1992","journal-title":"Am J Physiol"},{"key":"R147-18-20210213","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1152\/jappl.1993.74.5.2432","article-title":"TNF- and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidiasis.","volume":"74","author":"Matuschak","year":"1993","journal-title":"J Appl Physiol"},{"key":"R148-18-20210213","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/jir.1994.14.293","article-title":"Pentoxifylline inhibits tumor necrosis factor production in septic shock.","volume":"14","author":"Matuschak","year":"1994","journal-title":"J Interferon Res"},{"key":"R149-18-20210213","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00003246-199701000-00022","article-title":"The yeast-hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating TNF-.","volume":"25","author":"Matuschak","year":"1997","journal-title":"Crit Care Med"},{"key":"R150-18-20210213","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1084\/jem.180.6.2173","article-title":"Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis.","volume":"180","author":"Evans","year":"1994","journal-title":"J Exp Med"},{"key":"R151-18-20210213","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic siRNA in adult mice.","volume":"327","author":"Sorensen","year":"2003","journal-title":"J Mol Biol"},{"key":"R153-18-20210213","first-page":"623","article-title":"Pentoxyfylline-induced modulation of human leukocyte function in vitro.","volume":"136","author":"Josaki","year":"1990","journal-title":"Am J Pathol"},{"key":"R154-18-20210213","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00024382-199706000-00007","article-title":"A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor (TNF) and abrogates endotoxin-induced lethality.","volume":"7","author":"Solorzano","year":"1997","journal-title":"Shock"},{"key":"R155-18-20210213","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF03401909","article-title":"Selection of novel analogs of thalidomide with enhanced tumor necrosis factor inhibitory activity.","volume":"2","author":"Corral","year":"1996","journal-title":"Mol Med"},{"key":"R156-18-20210213","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/jsre.1996.0237","article-title":"Thalidomide inhibits TNF- response and increases survival following endotoxin injection in rats.","volume":"63","author":"Schmidt","year":"1996","journal-title":"J Surg Res"},{"key":"R157-18-20210213","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/IAI.70.6.2989-2994.2002","article-title":"Pirfenidone blocks the in vitro and in vivo effecs of staphylococcal enterotoxin B.","volume":"70","author":"Hale","year":"2002","journal-title":"Infect Immun"},{"key":"R158-18-20210213","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00003246-200103000-00029","article-title":"Effects of a dual inhibitor of tumor necrosis factor- and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein pathway.","volume":"29","author":"Yoshinari","year":"2001","journal-title":"Crit Care Med"},{"key":"R159-18-20210213","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.4049\/jimmunol.160.11.5506","article-title":"Control of Leishmania major infection in mice lacking TNF receptors.","volume":"160","author":"Nashleanas","year":"1998","journal-title":"J Immunol"},{"key":"R160-18-20210213","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.157.5.2155","article-title":"TNF- receptors in murine Candida albicans infection. Evidence for an important role of TNF- receptor p55 in antifungal defense.","volume":"157","author":"Steinshamn","year":"1996","journal-title":"J Immunol"},{"key":"R161-18-20210213","first-page":"257","article-title":"Resistance to cerebral malaria in tumor necrosis factor-\/-deficient mice is associated with a reduction of intercellular adhesion molecule-1 upregulation and TR helper type 1 response.","volume":"150","author":"Rudin","year":"1997","journal-title":"Am J Pathol"},{"key":"R162-18-20210213","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1084","article-title":"Such stuff as dreams are made on: mediator-targeted therapy in sepsis.","volume":"2","author":"Marshall","year":"2003","journal-title":"Nat Rev Drug Discov"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-200601000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:07:03Z","timestamp":1785856023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024382-200512001-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":158,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.shk.0000191343.21228.78","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}